PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
- 31 January 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8635) , 425-427
- https://doi.org/10.1016/s0140-6736(89)90014-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- INTRAPERITONEAL ERYTHROPOIETINThe Lancet, 1988
- SUBCUTANEOUS ERYTHROPOIETINThe Lancet, 1988
- SUBCUTANEOUS ERYTHROPOIETINThe Lancet, 1988
- The anemia of end-stage renal disease: Hematopoietic progenitor cell responseKidney International, 1988
- Evaluation of the stability of human erythropoietin in samples for radioimmunoassayJournal of Molecular Medicine, 1988
- The effect of molecular weight on the bioavailability of heparinThrombosis Research, 1987
- Bioequivalence of Genotropin and SomatonormActa Paediatrica, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin MixturesDiabetes Care, 1981
- Insulin resistance caused by massive degradation of subcutaneous insulinDiabetes, 1979